[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"status-days":3,"stock-4174":32,"stock-themes-4174":135},[4,18],{"date":5,"taiex_close":6,"taiex_chg":7,"taiex_chg_pct":8,"advancers":9,"decliners":10,"unchanged":11,"stocks":12,"turnover_sum":13,"margin_balance":14,"margin_chg":15,"short_balance":16,"short_chg":17},"2026-10-12",49301.96,-11.480000000003201,-0.00023279657634922568,868,916,158,1971,1044705369816,9174215,2895,175930,1165,{"date":19,"taiex_close":20,"taiex_chg":21,"taiex_chg_pct":22,"advancers":23,"decliners":24,"unchanged":25,"stocks":26,"turnover_sum":27,"margin_balance":28,"margin_chg":29,"short_balance":30,"short_chg":31},"2026-10-13",48341.31,-960.6500000000015,-0.019485026558781926,444,1337,161,1975,1306098703553,9070158,-104057,168869,-7061,{"profile":33,"snapshot":50,"data_version":134},{"code":34,"name":35,"full_name":36,"market":37,"kind":38,"industry":39,"listed_date":40,"chairman":41,"president":42,"capital":43,"shares":44,"founded_date":45,"website":46,"address":47,"english_name":48,"dividend_frequency":49},"4174","浩鼎","台灣浩鼎生技股份有限公司","otc","stock","生技醫療業","2015-03-23","梁賡義","陳雅琪",1315796870,131579687,"2002-04-29","https:\u002F\u002Fwww.obipharma.com","(115011)台北市南港區忠孝東路7段508號6樓","OBI","每年",{"code":34,"name":35,"market":37,"kind":38,"industry":39,"close":51,"chg":52,"chg_pct":53,"ret_5d":54,"ret_20d":55,"volume":56,"turnover":57,"mcap":58,"signals":59,"as_of":19,"ref_price":61,"ret_60d":62,"ret_ytd":63,"open":64,"high":65,"low":66,"pe":67,"pb":68,"dy":69,"foreign_net_1d":70,"foreign_net_5d":71,"trust_net_1d":69,"trust_net_5d":69,"dealer_net_1d":69,"dealer_net_5d":69,"foreign_holding_pct":72,"margin_balance":73,"margin_chg":74,"short_balance":75,"short_chg":76,"large_holder_pct":77,"large_holder_chg_1w":78,"large_holder_chg_4w":79,"holders_date":80,"high_52w":81,"low_52w":82,"rev_period":83,"rev_yoy":84,"eps_period":85,"eps":86,"spark":87},55.8,-1.7000000000000028,-0.029565217391304355,0.20779220779220764,1.1338432122370938,787463,43742268,7342146534.599999,[60],"eps_yoy",57.5,0.9476439790575917,0.033333333333333215,56.9,57.6,54,null,4.94,0,-92000,-796960,7.11,1360,-95,120,3,36.21,-1.2299999999999969,2.4200000000000017,"2026-10-09",58.9,22.85,"2026-09",-69.68,"2026-Q2",-2.043620710489536,[88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,102,95,103,100,104,105,102,106,107,108,108,95,109,110,111,100,112,113,114,115,113,116,117,118,100,119,98,117,120,92,121,122,123,124,125,126,127,128,129,130,131,132,133,61,51],27.7,28.25,27.9,28.05,27.75,27.55,27.1,26.3,25.55,24.9,25.1,26.85,26.15,26.25,25.95,26.55,26.75,26.35,25.75,25.6,26.9,26.1,26.7,26.4,25.4,25.05,25,24.6,24.95,26,26.45,25.45,26.65,27.2,29.9,29.65,32.6,32.45,35.65,39.2,43.1,42,46.2,50.8,52.1,53.7,"20261013-25697c",[136],{"theme":137,"segment":145,"tier":146,"role":147,"relevance":148,"note":149,"peers":150,"upstream":222,"downstream":229},{"id":138,"slug":139,"name":140,"category":141,"ret_1d":144},55,"new-drugs","新藥研發",{"slug":142,"name":143},"biotech","生技醫療",-0.02604453744683346,"新藥開發與臨床","upstream","challenger","high","癌症新藥開發",[151,166,179,190,201,212],{"code":152,"name":153,"role":154,"relevance":148,"note":155,"industry":39,"close":17,"chg_pct":156,"ret_5d":157,"ret_20d":158,"mcap":159,"turnover":160,"signals":161},"6446","藥華藥","leader","血液疾病新藥，已有上市產品",-0.016877637130801593,-0.021008403361344352,-0.11742424242424243,492134794500,1315551970,[162,163,60,164,165],"rev_yoy","rev_yoy_3m","trust_buy_5d","holders_up",{"code":167,"name":168,"role":169,"relevance":148,"note":170,"industry":39,"close":171,"chg_pct":172,"ret_5d":173,"ret_20d":174,"mcap":175,"turnover":176,"signals":177},"4743","合一","niche","傷口與皮膚新藥",47.55,-0.03451776649746208,0.009554140127388422,0.04390779363336983,22849367925,83204957,[60,178,165],"foreign_buy_5d",{"code":180,"name":181,"role":169,"relevance":148,"note":182,"industry":39,"close":183,"chg_pct":184,"ret_5d":185,"ret_20d":186,"mcap":187,"turnover":188,"signals":189},"4147","中裕","愛滋病抗體藥，已有上市產品",58.3,-0.036363636363636376,-0.028333333333333433,-0.0535714285714286,15927699919.999998,72544406,[],{"code":191,"name":192,"role":169,"relevance":148,"note":193,"industry":39,"close":194,"chg_pct":195,"ret_5d":196,"ret_20d":197,"mcap":198,"turnover":199,"signals":200},"4162","智擎","新藥開發與授權",56.5,-0.013961605584642212,0.027272727272727337,0.031021897810219023,8230784400,14152607,[162,60],{"code":202,"name":203,"role":169,"relevance":204,"note":205,"industry":39,"close":66,"chg_pct":206,"ret_5d":207,"ret_20d":208,"mcap":209,"turnover":210,"signals":211},"1760","寶齡富錦","mid","腎臟病用藥與保健品",-0.021739130434782594,0.0018552875695734272,-0.018181818181818077,4629906702,4998637,[162,60,178],{"code":213,"name":214,"role":147,"relevance":148,"note":149,"industry":39,"close":215,"chg_pct":216,"ret_5d":217,"ret_20d":218,"mcap":219,"turnover":220,"signals":221},"6550","北極星藥業-KY",15.9,-0.027522935779816682,-0.01851851851851838,-0.19039113027409926,14227203930.000002,8240813,[60,178,165],[223],{"id":224,"slug":225,"name":226,"category":227,"ret_1d":228},56,"cdmo-generics","CDMO 與學名藥",{"slug":142,"name":143},-0.010119884584519796,[]]